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doi:10.1016/j.ejvs.2011.04.022Abstract Introduction: The basic premise in managing patients with abdominal aortic aneu-
rysms (AAA) must be to reduce overall mortality from the disease. Operative mortality is
widely reported, but data on patients deemed unsuitable for repair are scarce. The purpose
of the present study was to report the fate of patients referred with AAA, to define the propor-
tion deemed unsuitable for surgery and to investigate the reasons for conservative treatment.
Methods: All patients who were referred to a regional vascular centre with large (>5.5 cm)
infra-renal AAA between 1st January 2008 and 31st December 2009 were included. Patients
were classified into two groups; those managed non-operatively, or those offered elective
repair. Survival was reported by KaplaneMeier analysis. Multivariate analysis investigated
factors leading to non-operative management.
Results: 251 patients with a mean (s.d.) age of 75(8) years were assessed. Thirty-two (13%)
patients were deemed unsuitable for repair, mostly because of medical co-morbidity (16/
32). 219/251 (87%) patients underwent repair (25/251 (10%) open repair 194/251 (77%) EVAR)
with 1/219 (0.5%) 30-day mortality. AAA repair was associated with significantly greater
survival (p < 0.001, log-rank test) at 2 years. In multivariate analysis Glasgow Aneurysm Score,
female gender and respiratory disease were significant predictors of the decision to treat
patients conservatively (p < 0.001).
Conclusion: Most patients were suitable for surgical intervention with low perioperative
mortality. Data on “turndown” rates should be routinely reported to quantify the denominator
for operative success.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.0 8725 3205; fax: þ44 020 8725 3495.
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The decision to repair an abdominal aortic aneurysm (AAA)
entails integration of the risk of rupture, the perioperative
risk of aneurysm repair, the patient’s life expectancy and
their preference regarding treatment. As the aim of AAA
repair is to prolong life through the prevention of rupture,
surgery should only be performed if the risk of rupture
outweighs the risk of surgery, in patients whose life
expectancy is long enough to result in long-term benefit.1,2
Lowering operative risk, without increasing the proportion
of patients denied surgery, maximises the population
benefit of elective AAA repair, and careful patient selection
is therefore of paramount importance.3,4
Relatively little is known regarding the natural history of
large AAA in patients deemed unsuitable for repair,5
although the EVAR-2 trial demonstrated no short-term
benefit of EVAR compared to no intervention in patients
unfit for open repair.6 No studies have compared the inci-
dence of factors affecting operative risk or life expectancy
between patients undergoing repair of large aneurysms
(>5.5 cm) and those managed non-operatively by an insti-
tution during the same time period.
There are surprisingly few studies that report the
proportion of patients with large aneurysms deemed
unsuitable for surgical intervention, even though these
data are required to place perioperative mortality in
context when quantifying performance. The extent of
selection bias affecting many reports therefore remains
difficult to quantify, as outcomes for managing patients
with AAA should encompass the entire cohort of patients
not just those undergoing operative repair. The primary aim
of this study was to define the proportion of patients with
large AAA managed non-operatively in a tertiary vascular
unit over a 2-year period, and to report their survival in
comparison to the cohort of patients undergoing operative
repair during the same period. A secondary aim of the study
was to examine the incidence of factors known to affect
operative risk and life expectancy and investigate their
impact on the decision to manage patients non-operatively.
Methods
A retrospective review of a prospectively maintained
database was undertaken of all patients assessed for repair
of an infra-renal AAA between 1/1/2008 and 31/12/2009.
Inclusion criteria comprised all patients with infra-renal
AAA referred for elective assessment, including patients
managed non-operatively. Exclusion criteria comprised
patients with ruptured or urgent AAA, aortic dissection,
suprarenal or thoracoabdominal aneurysms.
Patients were classified into two groups: those deemed
unsuitable for repair, or those offered elective surgery
(endovascular or open). In both groups, demographic and
clinical data were collected concerning operative risk and
co-morbidity. These data included patient demographics,
co-morbidity, pre-operative investigations, maximum
aneurysm diameter and pre-operative Glasgow Aneurysm
Score (GAS).7 The Glasgow Aneurysm Score is a perioper-
ative risk score for aneurysm repair which has been vali-
dated in open surgery, and this was calculated using itspublished definition: risk score Z (age in years) þ (17 for
shock) þ (7 for myocardial disease) þ (10 for cerebrovas-
cular disease) þ (14 for renal disease). The reasons for
deeming patients unsuitable for repair were classified
according to medical co-morbidity, adverse aneurysm
morphology or patient refusal. Co-morbidity was divided
into one or more organ systems (cardiovascular, respira-
tory, renal and cerebrovascular).
All patients (operated and unsuitable) were medically
managed with an antiplatelet agent, a statin and an anti-
hypertensive agent as per Society for Vascular Surgery
guidelines on AAA management.8 Perioperative mortality
was defined as in-hospital death or that within 30-days of
the procedure. Outcomes following EVAR were recorded as
per the SVS standard reporting criteria,9 including analysis
of long-term mortality from a central database.
Assessing suitability for aneurysm repair
Unit policy was to consider elective repair of all morpho-
logically suitable aneurysms >5.5 cm in diameter, with an
endovascular approach as the first line therapy. The unit
participates in the UK National Abdominal Aortic Aneurysm
Screening Programme (NAAASP),10 although none of the
patients reported were identified from screening. Specific
physiological criteria with strict cut-offs for surgery were
not used to define patients’ fitness for surgery. A combi-
nation of individual patient, physiological and aneurysm
morphological criteria were assessed in the round.
All patients underwent an electrocardiogram, routine
phlebotomy, transthoracic echocardiography and pulmo-
nary function tests. Where indicated, further cardiac
investigations were undertaken including dobutamine
stress echocardiogram, percutaneous coronary intervention
or coronary artery bypass. Patients were assessed on their
ability to climb two flights of stairs and 0.625 mm-cut spiral
computed tomography (CT) scans were used to assess
aneurysm morphology. Each case was discussed in
a combined vascular multidisciplinary team meeting and
was seen by a consultant vascular anaesthetist prior to
operative repair. All patients underwent pre-operative
optimisation of medical co-morbidity through referral to
specialist physicians where necessary. Details of this prac-
tice, which has been shown to improve outcome, have been
published previously.11 The final decision to undergo AAA
repair was taken by a consultant vascular surgeon in
consultation with the patient. Clearly, some patients
deemed unsuitable for aneurysm repair at an aortic diam-
eter of 5.5 cm, were reassessed if their aneurysm
expanded, as the concept of unsuitability remained relative
rather than absolute. The present study reports the result
of the final decision taken for each patient.
Statistical analysis
All patients managed non-operatively were identified and
the decision to advise against elective aneurysm repair at
that particular aortic diameter, was the primary outcome
measure. The secondary outcome measure assessed was
mortality. Statistical analyses were designed to determine
which factors affected the decision to advise against
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analysed using the Fisher’s exact or Chi Squared tests;
parametric continuous data were analysed using the
Student’s t-test, non-parametric continuous data were
analysed using the ManneWhitney U-test. Multivariate
analysis was performed using a binary logistic regression
model. A forward variable selection procedure was used,
incorporating variables significant in univariate analysis.
Inclusion in the model required a significance level of
a Z 0.1. Significant results were reported from the model
at a significance level of a Z 0.05.
Freedomfrommortalitywas reportedusingKaplaneMeier
survival analysis. The baseline for survival analysis was the
date of operation in patients undergoing operative repair,
and the date of the final decision to manage patients non-
operatively in the group who were refused repair. Subgroup
analysis was performed with the Peto log-rank test. All
analyses were performed using PASW Statistics version 18.0
software (SPSS, Chicago, Illinois, USA).
Results
Between 1 January 2008 and 31 December 2009, 251 patients
with a mean (s.d.) age of 75(8) years with infra-renal AAA
were assessed. 82%weremen, and themean (s.d.)maximum
aneurysm diameter was 65(14) mm. Median follow-upwas 18
(range 1e33) months. 32/251 (13%) patients were deemed
unsuitable for AAA repair at their current aortic diameter;
25/251 (10%) underwent open repair and 194/251 (77%)
underwent EVAR. 30-day mortality in the operated cohort
was 1/219 (0.5%), the median length of stay in hospital was 8
days (range 1e31 days). 87/219 (40%) operated patients
required post-operative ITU care and their median ITU stay
was 2.5 days (range 1e31days). 30-daymortality in the group
managed non-operatively was 1/32 patients (3%).
Patients deemed unsuitable for AAA repair
Themedian follow-upof32patientsmanagednon-operatively
was 6.5 months (range: 1e23 months). The mean maximum
AAAdiameterwas 67mm(0.8mm), and50%weremale. In this
group, no patients were younger than 65 years old, 9 patients
(28%) were aged 65e74, 11 (34%) were aged 75e84 and 12
(38%) were aged 85 or greater. Reasons for non-operative
management comprised significant lifestyle disabling
“medical co-morbidity” (16/32, 50%), combined co-morbidity
and aneurysm morphology (5/32, 16%) and aneurysm
morphology alone (3 patients, 9%) (Fig. 1). Seven patients
declined AAA repair (25%). One female patient was turned
down due to advanced age (91 years) and minimal serial
growth of her 5.6 cm aneurysm. The most common co-
morbidity underlying non-operative management was estab-
lished severe single-organ dysfunction (10/32, 31%),
predominantly severe chronic obstructive pulmonary disease.
Univariate analysis of decision to advise
conservative treatment
A number of factors were identified in univariate analysis as
being associated with the decision to recommend againstelective aneurysm surgery. These were increasing age,
female gender, lower estimated glomerular filtration rate
(eGFR),chronic renal disease, low forced expiratory volume
in 1 s (FEV1), chronic respiratory disease, previous cere-
brovascular disease, hypertension, smoking status, reduced
left ventricular shortening fraction, ischaemic heart disease
and higher Glasgow Aneurysm Score (GAS) (Table 1). There
was no significant difference in the rate of diabetes or
hyperlipidaemia between patients managed non-operatively
and patients who underwent AAA repair.
Multivariate analysis of decision for non-
operative management
Single-level multivariate logistic regression demonstrated
that higher Glasgow Aneurysm Score (GAS) (OR 1.111, 95%
CI 1.058e1.167, p < 0.001) chronic pulmonary disease (OR
10.892, 95% CI 3.621e32.765, p < 0.001) and female gender
(OR 11.256, 95% CI 3.960e31.996, p < 0.001) were signifi-
cant predictors of for the decision to advise against elective
surgery in multivariate analysis.
Survival analysis in operated patients and
patients deemed unsuitable for surgery
In patients managed non-operatively, survival at 1 month, 6
months, 1 year, 18 months and 2 years respectively was
94%, 91%, 52%, 40% and 35% respectively. In patients
undergoing AAA repair, survival at these timepoints was
99%, 92%, 90%, 85%, and 85% respectively (Fig. 2). There
was a significant survival advantage in the group who
underwent AAA repair (p < 0.001, log-rank test).
Discussion
Over a two-year period in which 251 patients with infra-
renal AAA were assessed, 13% were deemed unsuitable for
surgery at their current aortic diameter. The most common
reason for non-operative management was medical co-
morbidity, followed by hostile aneurysm morphology and
the patient’s own choice to refuse surgery. This result is
consistent with the few modern studies of aneurysm repair
that have published the proportion of patients who are
refused surgery, which is reported as a wide range of 8e35%
of those presenting to individual units following systematic
literature review (Table 2).
Comparison of results from different centres would be
greatly facilitated by the mandatory publication of turn-
down rates, which may be of great importance in inter-
preting the outcomes of aortic surgery. Heterogeneity in
turndown rates might contribute to the difference in
mortality from AAA repair seen across international data-
sets; for example in figures across Europe collected for the
Vascunet database.12 The present study was conducted at
a tertiary centre with endovascular expertise, which
constrains the applicability of these results. The wider
impact of turndown rates on outcomes may be studied in
the future through collection of these data using national
audit tools, such as the UK National Vascular Database13
and the UK NAAASP.10
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Figure 1 A flow-chart to illustrate the fate of 251 patients with infra-renal AAA referred to the tertiary vascular unit over a 2-
year period. Abbreviations, CVS: Cardiovascular System; RS: Respiratory System; AAA: Abdominal Aortic Aneurysm; EVAR: Endo-
vascular Aneurysm Repair.
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in patients deemed unsuitable for surgery, compared to
those who underwent operative repair. This finding high-
lights the high mortality associated with appropriately
selected patients with AAA who did not undergo surgery. A
limitation of this retrospective observational study was the
lack of information regarding cause of death, as few
patients underwent autopsy. This limits discussion of
whether an appropriate selection of cases was chosen for
operative management in local practice, as aneurysm-
related mortality in the non-operatively managed cohort
remained unquantified.
Operated patients had fewer significant co-morbidities,
and numerous factors were significantly associated withTable 1 Univariate analysis of factors leading to non-operative
Factor TurnDown
Age (years) 80.1  7.2
Male gender 16/32
GAS 92.2  11.9
eGFR (ml/min) 57.3  18.5
Renal Disease 13/29
Lung Disease 22/32
FEV1 (L) 1.3  0.4
Cerebrovascular Disease 9/27
Hypertension 27/30
Smoking 26/28
LV Shortening 25.9  20.1
Ischaemic Heart Disease 19/31
Diabetes 2/28
Hyperlipidaemia 15/27
Abbreviations: GAS, Glasgow Aneurysm Score; eGFR, estimated glom
Shortening, Left Ventricular Shortening.non-operative management using univariate analysis. In
multivariate analysis, only GAS, female gender and respi-
ratory disease appeared significant. In the present study
the most common co-morbidity underlying conservative
management was severe chronic obstructive pulmonary
disease (COPD), with nine patients being managed conser-
vatively because of end-stage COPD.
Risk scores such as the Glasgow Aneurysm Score (GAS)
have proved important in stratifying operative risk and have
been validated for the prediction of mortality after open
repair. Although a consideration of GAS reflects the greater
co-morbidity seen in patients who underwent conservative
management, its greater utility in predicting the outcome
of aneurysm repair in the endovascular era remainsmanagement.
Operated p-value
74.6  7.7 <0.001
191/214 <0.001
81.1  10.7 <0.001
73.9  24.4 <0.001
36/215 <0.001
47/215 <0.001
2.1  0.8 0.005
29/215 0.008
143/215 0.009
159/215 0.027
35.1  11.1 0.037
90/215 0.042
32/215 0.267
132/215 0.558
erular filtration rate; FEV1, Forced expiratory volume in 1 s; LV
Figure 2 KaplaneMeier Survival in patients not operated upon, or undergoing AAA repair. )p-values obtained from log-rank test
comparison between the survival of patients undergoing AAA repair and patients turned down for repair.
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dated for open repair has suggested that none of the
available scores predict the outcome of EVAR accurately
enough to be recommended for clinical use in individual
patients.14 Therefore, the prospective role of such scoring
systems should remain limited within the complexTable 2 Reported turndown rates; studies which state the propo
but treated non-operatively.
Author Study Period
Szilagyi 196634 1944e1965
Bardram 198035 1970e1979
Perko 199336 1979e1988
Ruberti 198537 1965e1983
Campbell 198638 1979e1984
Woodburn 200139 1998e1999
Heikennen 200240 1990e1998
Tambyraja 200341 1995e1999
Tanquilut 200242 1994e2000consideration of whether to offer patients surgery for AAA
until risk scores can be validated for EVAR.
The role of female gender was in the decision to offer
surgery for AAA was significant in multivariate analysis. This
is consistent with the literature concerning gender and
operative risk, as several studies have demonstrated poorerrtion of all patients referred with abdominal aortic aneurysm
Turndown Rate Operative Techniques
32% (223/703) Open
22% (43/197) Open
11% (79/735) Open
9% (53/594) Open
12% (18/153) Open
35% (35/115) Open and EVAR
18% (35/194) Open and EVAR
28% (128/457) Open
8% (19/226) Open and EVAR
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repair in female patients. The increased operative risk
associated with AAA in female patients should be incorpo-
rated into the complex consideration of the decision to
operate.15e19
As the goal of elective AAA repair is to prolong life in
a population of patients by preventing rupture, the decision
to refuse surgery requires a balance of the risk of rupture
without operative repair, the risk of death unrelated to
rupture, the patient-specific risk of post-operative
mortality and their preference.8 The risk of rupture
without surgery is dependent on the natural history of
aneurysmal disease. There is a consensus that aneurysms
larger than 5.5 cm mandate repair in fit candidates,20 so
attempts to quantify the probability of rupture of
untreated large aneurysms rely on a highly selected group
of patients unfit for surgery or refusing surgery, and have
produced heterogeneous data.21
In previous studies the majority of patients unfit for
surgery died from causes other than rupture, namely
cardiorespiratory disease, and few would have benefited
from AAA repair.22 Conversely, others have found that AAA
rupture was the predominant cause of death in patients
with an untreated AAA >5.5 cm, with a median time to
rupture of just 9 months in patients with AAA >7 cm.16 The
Veterans Affairs Study demonstrated a 9.4% 1-year risk of
rupture in unoperated AAA of 5.5e5.9 cm, rising to 32.5% in
AAA greater than 7 cm.
Data from the EVAR-2 trial suggested no survival
advantage was delivered by EVAR in poor surgical candi-
dates.6 Prospective and randomised natural history
studies may underestimate rupture risk as the indication
for surgery changes in relation to aneurysm growth.
Clearly, many factors other than aneurysm size may
contribute to rupture risk, including peak wall stress23 or
the high level of optimal medical therapy delivered to
conservatively managed patients.6 A recent meta-analysis
suggested a rupture rate of 27 per 100 patient years for
aneurysms >6 cm diameter, and a randomised trial of
surveillance versus intervention remains unlikely for large
aneurysms.21
Important limitations of the present descriptive study
include the greater prevalence of co-morbidity in patients
not offered AAA repair, the lack of information regarding
cause of death in those managed conservatively, and the
applicability of these results outside tertiary centres.
Furthermore, the group of patients managed non-
operatively in the present report were heterogeneous;
with underlying reasons including medical co-morbidity
(without strict cut-off criteria), adverse aneurysm
morphology, patient refusal and advanced age relative to
the group of patients undergoing AAA repair. This limited
comparative analysis with patients offered repair. Greater
knowledge of patient preference,24e28 the refinement of
physiological scoring systems to predict outcome after
open AAA repair29,30 and morphological scoring systems
for outcome after EVAR31,32 will add to the data available
to surgeons evaluating the decision to treat AAA. With the
development of more accurate risk stratification,
computer-aided decision modelling may represent
a useful adjunct to clinical judgement in high-risk and
complex cases.33Conclusion
In conclusion, few studies have published the rate at which
patients have been turned down for AAA repair, yet these
data are important in defining institutional performance.
Without the publication of turndown rates and the wide-
spread use of a more robust risk scoring system for peri-
operative mortality, it is difficult to comprehensively
compare outcomes between centres. Future studies of AAA
repair should routinely report the proportion of patients
turned down for surgery.Conflict of Interest/Funding
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